GAITHERSBURG, MARYLAND, USA, September 11, 2023 – LKC Technologies, a leader in functional testing using electroretinography (ERG), announces the release of a new report on diabetic retinopathy (DR). Modern Fundamentals of Diabetic Retinopathy Management in Optometry is a consensus document developed by an optometric task force comprised of medical optometry educators. This panel endeavored to simplify and standardize DR assessment and management to avoid preventable vision loss.

The group’s inaugural meeting was held in 2022 and was led by Paul Chous, MA, OD, FAAO, of Chous Eye Care Associates in Tacoma, WA. At the first meeting, every member of the task force agreed that structure, although important, isn’t enough to comprehensively monitor patients who have diabetic eye disease. Rather, to properly stage DR and to safely assess risk of progression, both structural and functional measures are needed. Furthermore, the group concluded, subjective findings such as visual acuity are a poor surrogate for objective functional tests, such as ERG.

“There is a dire need for an elevated protocol to guide patient care in DR,” says Jeffry D. Gerson, OD, FAAO, of Grin Eye Care in Olathe, KS. “The sad reality is that the complexity of this disease and the subjectivity of many of our tests can lead to errors and vision loss.”

The members of the task force believe that optometrists can do better for patients who have diabetes, and they are responding to a need to make the diagnosis and management of DR easier to implement in a clinical setting.

“The group strove to develop recommendations that would be practical to implement,” says Dr. Chous. “Our goal was to elevate the standard of care with proper management and vigilance, even given the challenges posed by today’s busy healthcare environments.”

To that end, Fundamentos modernos del tratamiento de la retinopatía diabética en optometría presents a framework that will radically simplify DR management so that optometrists can confidently care for the growing population of patients with diabetes. The guidelines are based on five pillars, all of which are backed by evidence-based science. Briefly, the five pillars are as follows: